Ubs Group AG Schedule 13G passive stakes

UBS Group AG has reported beneficial ownership of 8.1% of Summit Hotel Properties, Inc.'s common stock as of June 30, 2026.

UBS Group AG has filed a Schedule 13G, indicating beneficial ownership of 5.78% of IHS Holding Ltd's ordinary shares.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 5.45% of Rising Dragon Acquisition Corp.'s common stock.

UBS Group AG has filed a Schedule 13G detailing its beneficial ownership of Starlink AI Acquisition Corp units, holding 5.4% of the class.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 30.0% of abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares.

UBS Group AG has filed a Schedule 13G, disclosing beneficial ownership of 2,170,665 common shares, representing 6.6% of the outstanding shares in Nuveen California Municipal Value Fund.

UBS Group AG has filed a Schedule 13G, reporting no beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30, 2026.

UBS Group AG has filed an amendment to its Schedule 13G, correcting the event date for its previous filing concerning AMC Entertainment Holdings, Inc. Class A common stock.

UBS Group AG has filed an amended Schedule 13G, reporting 0% beneficial ownership of AMC Entertainment Holdings, Inc. Class A common stock as of December 31, 2025.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 16,129,947 Class A ordinary shares of Vipshop Holdings Ltd, representing 20.0% of the class.

UBS Group AG has reported beneficial ownership of 746,095 shares, representing 5.8% of the outstanding common stock of Reviva Pharmaceuticals Holdings, Inc., as of March 31, 2026.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 762,688 units, representing 5.4% of APEX Tech Acquisition Inc.'s outstanding securities.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 17,141,817 shares, or approximately 5.5%, of Amicus Therapeutics, Inc. common stock.

UBS Group AG has filed a Schedule 13G reporting a 33.2% beneficial ownership stake in abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares.

UBS Group AG has disclosed a 5.4% beneficial ownership stake in Nuveen California Municipal Value Fund, holding 1,792,995 common shares.

UBS Group AG has reported a 6.2% beneficial ownership stake in AMC Entertainment Holdings, Inc., holding over 31.7 million Class A common shares as of December 31, 2025.

UBS Group AG has reported a significant beneficial ownership of 34.9% in abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares.

UBS Group AG has reported a significant 40.6% beneficial ownership stake in abrdn Income Credit Strategies Fund's Series A Perpetual Preferred Shares.

UBS Group AG has filed an amendment to its Schedule 13G, revealing a significant beneficial ownership of 42.68% in abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares.

UBS Group AG has filed an amended Schedule 13G, indicating it no longer holds any beneficial ownership in Rapid7, Inc. common stock.

UBS Group AG has filed an amended Schedule 13G, reporting a beneficial ownership of 5.23% in Rapid7, Inc.'s common stock as of March 31, 2025.

UBS Group AG has filed an amendment to its Schedule 13G for Renalytix plc, primarily to correct the 'Date of Event Which Requires Filing of this Statement' to March 31, 2025.

UBS Group AG has filed an amended Schedule 13G, indicating it no longer holds any beneficial ownership in Renalytix plc, with its stake reduced to 0.0% as of the event date.

UBS Group AG has filed an amended Schedule 13G, indicating it no longer beneficially owns any common stock of PIMCO Access Income Fund as of March 31, 2025.

UBS Group AG has filed an amended Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in Color Star Technology Co., Ltd.

UBS Group AG has reported a beneficial ownership of 5.8% in Western Asset Investment Grade Opportunity Trust Inc., holding 345,414 shares as of March 31, 2025.

UBS Group AG has filed an amended Schedule 13G, reporting a 44.3% beneficial ownership stake in abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares as of March 31, 2025.

UBS Group AG has filed an amended Schedule 13G, indicating it no longer beneficially owns any common stock of Infinera Corp as of March 31, 2025.

UBS Group AG has filed an amendment to its Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in The Clorox Company as of March 31, 2025.

UBS Group AG has disclosed a beneficial ownership of 8.15% in Clorox Co., totaling 10,084,448 shares, as of December 31, 2024, clarifying a previous administrative inclusion.